SCHEMBL7137131

SCHEMBL7137131

CC(C)(C)OC(=O)NCCCOc1ccc(N)c2c1CCCC2=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 6/20 0.45
CA2 P00918 6/20 0.45
CA12 O43570 5/20 0.45
CA9 Q16790 5/20 0.45
CYP2D6 P10635 2/20 0.41
CYP2C19 P33261 2/20 0.41
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
LMNA P02545 2/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 2/20 0.40
HSD17B10 Q99714 2/20 0.40
KDM4E B2RXH2 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
CASP1 P29466 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7135351 0.84 CA12 (0.42) CA1CA2CA12CA9CYP2D6
SCHEMBL10110801 0.79 DRD2 (0.48) CA1CA2CA12CA9CYP2D6
SCHEMBL18025999 0.76 CA1 (0.56) CA1CA2CA12CA9CYP2D6
SCHEMBL25694199 0.76 MAPT (0.41) CA1CA2CYP2D6CYP2C19ALDH1A1
SCHEMBL6760543 0.75 LTB4R (0.42) CA1CA2CA12CA9CYP2D6
SCHEMBL25692600 0.75 AAK1 (0.39) CA1CA12CA9ALDH1A1MEN1
SCHEMBL706941 0.75 CA12 (0.45) CA1CA2CA12CA9CYP2D6
SCHEMBL16123200 0.74 CA12 (0.51) CA1CA2CA12CA9CYP2D6
SCHEMBL709548 0.74 CA1 (0.44) CA1CA2CA12CA9CYP2D6
SCHEMBL16572306 0.73 CA1 (0.48) CA1CA2CA12CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6617456-B1 Aminoalkoxy- or hydroxyalkoxy- camptothecin compound that can be bound to a polysaccharide having carboxyl groups via an amino acid or a peptide group; antitumor agents TANABE SEIYAKU CO., LTD. (JP) 2003-09-09 US disclosed
US-6512118-B1 Pharmaceutically acceptable salt thereof show excellent antitumor activities against various tumors, especially they show excellent therapeutic effects on solid tumors such as pulmonary cancer, uterine cancer, ovarian cancer, breast TANABE SEIYAKU CO., LTD. (JP) 2003-01-28 US disclosed
EP-0781781-B1 Camptothecin derivatives TANABE SEIYAKU CO (JP) 2001-10-10 EP disclosed
US-5892043-A MIXTURE WITH POLYSACCHARIDE AND PEPTIDE; ANTITUMOR AGENT TANABE SEIYAKU CO., LTD. (JP) 1999-04-06 US disclosed
EP-0781781-A2 Camptothecin derivatives TANABE SEIYAKU CO., LTD. (JP) 1997-07-02 EP disclosed